Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.DaVita HealthCare Partners ( DVA) pushed the Health Services industry higher today making it today's featured health services winner. The industry as a whole closed the day up 0.1%. By the end of trading, DaVita HealthCare Partners rose $3.91 (6.7%) to $62.17 on heavy volume. Throughout the day, 5,652,172 shares of DaVita HealthCare Partners exchanged hands as compared to its average daily volume of 1,826,400 shares. The stock ranged in a price between $58.47-$62.78 after having opened the day at $58.48 as compared to the previous trading day's close of $58.26. Other companies within the Health Services industry that increased today were: Given Imaging ( GIVN), up 27.1%, NeuroMetrix ( NURO), up 12.8%, Arrhythmia Research Technology ( HRT), up 8.6% and SunLink Health Systems ( SSY), up 8.5%.
DaVita HealthCare Partners Inc. provides kidney dialysis services for patients suffering from chronic kidney failure, or end stage renal disease (ESRD) in the United States. DaVita HealthCare Partners has a market cap of $12.1 billion and is part of the health care sector. The company has a P/E ratio of 21.5, above the S&P 500 P/E ratio of 17.7. Shares are up 3.4% year to date as of the close of trading on Friday. Currently there are 7 analysts that rate DaVita HealthCare Partners a buy, no analysts rate it a sell, and 5 rate it a hold. TheStreet Ratings rates DaVita HealthCare Partners as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, good cash flow from operations and increase in stock price during the past year. We feel these strengths outweigh the fact that the company has had sub par growth in net income.